Chicken gga-miR-130a targets HOXA3 and MDFIC and inhibits Marek’s disease lymphoma cell proliferation and migration

Molecular Biology Reports

Volumn 43, Issue 7, 2016, Pages 667-676

  Han, Bo ^a   Lian, Ling ^a   Li, Xin ^a   Zhao, Chunfang ^a   Qu, Lujiang ^a   Liu, Changjun ^b   Song, Jiuzhou ^c   Yang, Ning ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b INSTITUTE OF PLANT PROTECTION   (China)

^c UNIVERSITY OF MARYLAND   (United States)

Author keywords

Cell migration; Cell proliferation; Chicken; gga miR 130a; HOXA3; Marek s disease; MDFIC

Indexed keywords

CELL PROTEIN; GGA MICRORNA 130A; HOMEOBOX A3 PROTEIN; MESSENGER RNA; MICRORNA; MYOD FAMILY INHIBITOR DOMAIN CONTAINING PROTEIN; RNA 5S; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; AVIAN PROTEIN; HOMEODOMAIN PROTEIN; MYOGENIC FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CANCER GROWTH; CANCER INHIBITION; CARCINOGENESIS; CELL MIGRATION; CHICKEN; CONTROLLED STUDY; DOWN REGULATION; GENE; GENE CLUSTER; GENE FUNCTION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC RESISTANCE; HOXA3 GENE; LYMPHOID CELL; LYMPHOMA; LYMPHOMA CELL; MAREK DISEASE; MDFIC GENE; NONHUMAN; PREDICTION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SPLEEN; VALIDATION STUDY; WESTERN BLOTTING; 3' UNTRANSLATED REGION; ANIMAL; CELL MOTION; CELL PROLIFERATION; GENE EXPRESSION; GENETICS; MAREK'S DISEASE VIRUS 1; METABOLISM; PATHOLOGY; PHYSIOLOGY; RNA INTERFERENCE; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; ANIMALS; AVIAN PROTEINS; BINDING SITES; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CHICKENS; GENE EXPRESSION; HERPESVIRUS 2, GALLID; HOMEODOMAIN PROTEINS; MAREK DISEASE; MICRORNAS; MYOGENIC REGULATORY FACTORS; RNA INTERFERENCE; SPLEEN;

EID: 84968616024     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-016-4002-2     Document Type: Article

References (82)

1. Kottaridis SD (1969) Marek’s disease: a review. Worlds Poult Sci J 25(1):35–45
2. Gennart I, Coupeau D, Pejakovic S, Laurent S, Rasschaert D, Muylkens B (2015) Marek’s disease: genetic regulation of gallid herpesvirus 2 infection and latency. Vet J 205(3):339–348. doi:10.1016/j.tvjl.2015.04.038
3. Marek J (1907) Multiple nervenentzuendung (polyneuritis) bei huehnern. Deutsche Tierärztliche Wochenschrift 15:417–421
4. Morrow C, Fehler F (2004) Marek’s disease: a worldwide problem. In: Davidson F, Nair V (eds) Marek’s Disease: an evolving problem. Elsevier Academic Press, London, pp 49–61
5. Calnek BW (2001) Pathogenesis of Marek’s disease virus infection. Curr Top Microbiol Immunol 255:25–55
6. Calnek BW (1986) Marek’s disease—a model for herpesvirus oncology. Crit Rev Microbiol 12(4):293–320
7. Baigent SJ, Smith LP, Nair VK, Currie RJ (2006) Vaccinal control of Marek’s disease: current challenges, and future strategies to maximize protection. Vet Immunol Immunopathol 112(1–2):78–86. doi:10.1016/j.vetimm.2006.03.014
8. Gimeno IM (2008) Marek’s disease vaccines: a solution for today but a worry for tomorrow? Vaccine 26(Suppl 3):C31–C41
9. Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136(2):215–233. doi:10.1016/j.cell.2009.01.002
10. Fabian MR, Sonenberg N, Filipowicz W (2010) Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 79:351–379. doi:10.1146/annurev-biochem-060308-103103
11. Giraldez AJ, Cinalli RM, Glasner ME, Enright AJ, Thomson JM, Baskerville S, Hammond SM, Bartel DP, Schier AF (2005) MicroRNAs regulate brain morphogenesis in zebrafish. Science 308(5723):833–838. doi:10.1126/science.1109020
12. Naguibneva I, Ameyar-Zazoua M, Polesskaya A, Ait-Si-Ali S, Groisman R, Souidi M, Cuvellier S, Harel-Bellan A (2006) The microRNA miR-181 targets the homeobox protein Hox-A11 during mammalian myoblast differentiation. Nat Cell Biol 8(3):278–284. doi:10.1038/ncb1373
13. Xu YP, Qi RQ, Chen W, Shi Y, Cui ZZ, Gao XH, Chen HD, Zhou L, Mi QS (2012) Aging affects epidermal Langerhans cell development and function and alters their miRNA gene expression profile. Aging (Albany NY) 4(11):742–754
14. Brennecke J, Hipfner DR, Stark A, Russell RB, Cohen SM (2003) bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell 113(1):25–36. doi:10.1016/S0092-8674(03)00231-9
15. Chen L, Guan H, Gu C, Cao Y, Shao J, Wang F (2015) miR-383 inhibits hepatocellular carcinoma cell proliferation via targeting APRIL. Tumour Biol. doi:10.1007/s13277-015-4071-1
16. Xiao R, Li C, Chai B (2015) miRNA-144 suppresses proliferation and migration of colorectal cancer cells through GSPT1. Biomed Pharmacother 74:138–144. doi:10.1016/j.biopha.2015.08.006
17. Rebucci M, Sermeus A, Leonard E, Delaive E, Dieu M, Fransolet M, Arnould T, Michiels C (2015) miRNA-196b inhibits cell proliferation and induces apoptosis in HepG2 cells by targeting IGF2BP1. Mol Cancer 14:79. doi:10.1186/s12943-015-0349-6
18. Que T, Song Y, Liu Z, Zheng S, Long H, Li Z, Liu Y, Wang G, Liu Y, Zhou J, Zhang X, Fang W, Qi S (2015) Decreased miRNA-637 is an unfavorable prognosis marker and promotes glioma cell growth, migration and invasion via direct targeting Akt1. Oncogene 34(38):4952–4963. doi:10.1038/onc.2014.419
19. Xia Z, Liu F, Zhang J, Liu L (2015) Decreased expression of MiRNA-204-5p contributes to glioma progression and promotes glioma cell growth, migration and invasion. PLoS One 10(7):e0132399. doi:10.1371/journal.pone.0132399
20. Staton AA, Knaut H, Giraldez AJ (2011) miRNA regulation of Sdf1 chemokine signaling provides genetic robustness to germ cell migration. Nat Genet 43(3):204–211. doi:10.1038/ng.758
21. Cheng AM, Byrom MW, Shelton J, Ford LP (2005) Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res 33(4):1290–1297. doi:10.1093/nar/gki200
22. Hauser B, Zhao Y, Pang X, Ling Z, Myers E, Wang P, Califano J, Gu X (2015) Functions of MiRNA-128 on the regulation of head and neck squamous cell carcinoma growth and apoptosis. PLoS One 10(3):e0116321. doi:10.1371/journal.pone.0116321
23. Calin GA, Croce CM (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6(11):857–866. doi:10.1038/nrc1997
24. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR (2005) MicroRNA expression profiles classify human cancers. Nature 435(7043):834–838. doi:10.1038/nature03702
25. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CM (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103(7):2257–2261. doi:10.1073/pnas.0510565103
26. Farazi TA, Hoell JI, Morozov P, Tuschl T (2013) MicroRNAs in human cancer. Adv Exp Med Biol 774:1–20. doi:10.1007/978-94-007-5590-1_1
27. Burnside J, Bernberg E, Anderson A, Lu C, Meyers BC, Green PJ, Jain N, Isaacs G, Morgan RW (2006) Marek’s disease virus encodes microRNAs that map to meq and the latency-associated transcript. J Virol 80(17):8778–8786. doi:10.1128/Jvi.00831-06
28. Burnside J, Ouyang M, Anderson A, Bernberg E, Lu C, Meyers BC, Green PJ, Markis M, Isaacs G, Huang E, Morgan RW (2008) Deep sequencing of chicken microRNAs. BMC Genom 9:185. doi:10.1186/1471-2164-9-185
29. Morgan R, Anderson A, Bernberg E, Kamboj S, Huang E, Lagasse G, Isaacs G, Parcells M, Meyers BC, Green PJ, Burnside J (2008) Sequence conservation and differential expression of Marek’s disease virus microRNAs. J Virol 82(24):12213–12220. doi:10.1128/JVI.01722-08
30. Zhao Y, Yao Y, Xu H, Lambeth L, Smith LP, Kgosana L, Wang X, Nair V (2009) A functional MicroRNA-155 ortholog encoded by the oncogenic Marek’s disease virus. J Virol 83(1):489–492. doi:10.1128/JVI.01166-08
31. Luo J, Sun AJ, Teng M, Zhou H, Cui ZZ, Qu LH, Zhang GP (2011) Expression profiles of microRNAs encoded by the oncogenic Marek’s disease virus reveal two distinct expression patterns in vivo during different phases of disease. J Gen Virol 92(Pt 3):608–620. doi:10.1099/vir.0.024158-0
32. Xu S, Xue C, Li J, Bi Y, Cao Y (2011) Marek’s disease virus type 1 microRNA miR-M3 suppresses cisplatin-induced apoptosis by targeting Smad2 of the transforming growth factor beta signal pathway. J Virol 85(1):276–285. doi:10.1128/JVI.01392-10
33. Zhao Y, Xu H, Yao Y, Smith LP, Kgosana L, Green J, Petherbridge L, Baigent SJ, Nair V (2011) Critical role of the virus-encoded microRNA-155 ortholog in the induction of Marek’s disease lymphomas. PLoS Pathog 7(2):e1001305. doi:10.1371/journal.ppat.1001305
34. Lian L, Qu L, Chen Y, Lamont SJ, Yang N (2012) A systematic analysis of miRNA transcriptome in Marek’s disease virus-induced lymphoma reveals novel and differentially expressed miRNAs. PLoS One 7(11):e51003. doi:10.1371/journal.pone.0051003
35. Tian F, Luo J, Zhang H, Chang S, Song J (2012) MiRNA expression signatures induced by Marek’s disease virus infection in chickens. Genomics 99(3):152–159. doi:10.1016/j.ygeno.2011.11.004
36. Hicks JA, Liu HC (2013) Current state of Marek’s disease virus microRNA research. Avian Dis 57(2 Suppl):332–339. doi:10.1637/10355-090812-Review.1
37. Li X, Lian L, Zhang D, Qu L, Yang N (2014) gga-miR-26a targets NEK6 and suppresses Marek’s disease lymphoma cell proliferation. Poult Sci 93(5):1097–1105. doi:10.3382/ps.2013-03656
38. Li ZJ, Zhang YP, Li Y, Zheng HW, Zheng YS, Liu CJ (2014) Distinct expression pattern of miRNAs in Marek’s disease virus infected-chicken splenic tumors and non-tumorous spleen tissues. Res Vet Sci 97(1):156–161. doi:10.1016/j.rvsc.2014.04.003
39. Yu ZH, Teng M, Sun AJ, Yu LL, Hu B, Qu LH, Ding K, Cheng XC, Liu JX, Cui ZZ, Zhang GP, Luo J (2014) Virus-encoded miR-155 ortholog is an important potential regulator but not essential for the development of lymphomas induced by very virulent Marek’s disease virus. Virology 448:55–64. doi:10.1016/j.virol.2013.09.017
40. Chi JQ, Teng M, Yu ZH, Xu H, Su JW, Zhao P, Xing GX, Liang HD, Deng RG, Qu LH, Zhang GP, Luo J (2015) Marek’s disease virus-encoded analog of microRNA-155 activates the oncogene c-Myc by targeting LTBP1 and suppressing the TGF-beta signaling pathway. Virology 476:72–84. doi:10.1016/j.virol.2014.11.027
41. Lian L, Li X, Zhao C, Han B, Qu L, Song J, Liu C, Yang N (2015) Chicken gga-miR-181a targets MYBL1 and shows an inhibitory effect on proliferation of Marek’s disease virus-transformed lymphoid cell line. Poult Sci 94(11):2616–2621. doi:10.3382/ps/pev289
42. Lian L, Qu LJ, Zheng JX, Liu CJ, Zhang YP, Chen YM, Xu GY, Yang N (2010) Expression profiles of genes within a subregion of chicken major histocompatibility complex B in spleen after Marek’s disease virus infection. Poult Sci 89(10):2123–2129. doi:10.3382/ps.2010-00919
43. Arocho A, Chen B, Ladanyi M, Pan Q (2006) Validation of the 2-DeltaDeltaCt calculation as an alternate method of data analysis for quantitative PCR of BCR-ABL P210 transcripts. Diagn Mol Pathol 15(1):56–61
44. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25(4):402–408. doi:10.1006/meth.2001.1262
45. Akiyama Y, Kato S (1974) Two cell lines from lymphomas of Marek’s disease. Biken J 17(3):105–116
46. Nazerian K (1987) An updated list of avian cell lines and transplantable tumours. Avian Pathol 16(3):527–544. doi:10.1080/03079458708436402
47. Goryo M, Suwa T, Matsumoto S, Umemura T, Itakura C (1987) Serial propagation and purification of chicken anaemia agent in MDCC-MSB1 cell line. Avian Pathol 16(1):149–163. doi:10.1080/03079458708436360
48. Kurien BT, Scofield RH (2006) Western blotting. Methods 38(4):283–293. doi:10.1016/j.ymeth.2005.11.007
49. Lian L, Qu LJ, Sun HY, Chen YM, Lamont SJ, Liu CJ, Yang N (2012) Gene expression analysis of host spleen responses to Marek’s disease virus infection at late tumor transformation phase. Poult Sci 91(9):2130–2138. doi:10.3382/ps.2012-02226
50. Zhou YM, Liu J, Sun W (2014) MiR-130a overcomes gefitinib resistance by targeting met in non-small cell lung cancer cell lines. Asian Pac J Cancer Prev 15(3):1391–1396
51. Jiang H, Yu WW, Wang LL, Peng Y (2015) miR-130a acts as a potential diagnostic biomarker and promotes gastric cancer migration, invasion and proliferation by targeting RUNX3. Oncol Rep 34(3):1153–1161. doi:10.3892/or.2015.4099
52. Lee SH, Jung YD, Choi YS, Lee YM (2015) Targeting of RUNX3 by miR-130a and miR-495 cooperatively increases cell proliferation and tumor angiogenesis in gastric cancer cells. Oncotarget 6(32):33269–33278
53. Li N, Yang L, Wang H, Yi T, Jia X, Chen C, Xu P (2015) MiR-130a and MiR-374a function as novel regulators of cisplatin resistance in human ovarian cancer A2780 cells. PLoS One 10(6):e0128886. doi:10.1371/journal.pone.0128886
54. Li NW, Wang HJ, Yang LY, Jia XB, Chen C, Wang X (2013) Regulatory effects and associated mechanisms of miR-130a molecules on cisplatin resistance in ovarian cancer A2780 cell lines. Sichuan Da Xue Xue Bao Yi Xue Ban 44(6):865–870
55. Yang L, Li N, Wang H, Jia X, Wang X, Luo J (2012) Altered microRNA expression in cisplatin-resistant ovarian cancer cells and upregulation of miR-130a associated with MDR1/P-glycoprotein-mediated drug resistance. Oncol Rep 28(2):592–600. doi:10.3892/or.2012.1823
56. Yang LY, Wang HJ, Jia XB, Wang X, Luo J, Zhang XY (2012) Expression of miR-130a in cisplatin resistant cell lines of ovarian cancer. Sichuan Da Xue Xue Bao Yi Xue Ban 43(1):60–64
57. Zhang X, Huang L, Zhao Y, Tan W (2013) Downregulation of miR-130a contributes to cisplatin resistance in ovarian cancer cells by targeting X-linked inhibitor of apoptosis (XIAP) directly. Acta Biochim Biophys Sin (Shanghai) 45(12):995–1001. doi:10.1093/abbs/gmt113
58. He L, Wang HY, Zhang L, Huang L, Li JD, Xiong Y, Zhang MY, Jia WH, Yun JP, Luo RZ, Zheng M (2014) Prognostic significance of low DICER expression regulated by miR-130a in cervical cancer. Cell Death Dis 5:e1205. doi:10.1038/cddis.2014.127
59. Zhang J, Wu H, Li P, Zhao Y, Liu M, Tang H (2014) NF-kappaB-modulated miR-130a targets TNF-alpha in cervical cancer cells. J Transl Med 12:155. doi:10.1186/1479-5876-12-155
60. Fujita Y, Kojima T, Kawakami K, Mizutani K, Kato T, Deguchi T, Ito M (2015) miR-130a activates apoptotic signaling through activation of caspase-8 in taxane-resistant prostate cancer cells. Prostate 75(14):1568–1578. doi:10.1002/pros.23031
61. Li T, Wu R, Zhang Y, Zhu D (2011) A systematic analysis of the skeletal muscle miRNA transcriptome of chicken varieties with divergent skeletal muscle growth identifies novel miRNAs and differentially expressed miRNAs. BMC Genom 12:186. doi:10.1186/1471-2164-12-186
62. Wang W, Du ZQ, Cheng B, Wang Y, Yao J, Li Y, Cao Z, Luan P, Wang N, Li H (2015) Expression profiling of preadipocyte microRNAs by deep sequencing on chicken lines divergently selected for abdominal fatness. PLoS One 10(2):e0117843. doi:10.1371/journal.pone.0117843
63. Wu WH, Hu CP, Chen XP, Zhang WF, Li XW, Xiong XM, Li YJ (2011) MicroRNA-130a mediates proliferation of vascular smooth muscle cells in hypertension. Am J Hypertens 24(10):1087–1093. doi:10.1038/ajh.2011.116
64. Pan Y, Wang R, Zhang F, Chen Y, Lv Q, Long G, Yang K (2015) MicroRNA-130a inhibits cell proliferation, invasion and migration in human breast cancer by targeting the RAB5A. Int J Clin Exp Pathol 8(1):384–393
65. Chen Y, Gorski DH (2008) Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5. Blood 111(3):1217–1226. doi:10.1182/blood-2007-07-104133
66. Xu N, Shen C, Luo Y, Xia L, Xue F, Xia Q, Zhang J (2012) Upregulated miR-130a increases drug resistance by regulating RUNX3 and Wnt signaling in cisplatin-treated HCC cell. Biochem Biophys Res Commun 425(2):468–472. doi:10.1016/j.bbrc.2012.07.127
67. Acunzo M, Visone R, Romano G, Veronese A, Lovat F, Palmieri D, Bottoni A, Garofalo M, Gasparini P, Condorelli G, Chiariello M, Croce CM (2012) miR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222. Oncogene 31(5):634–642. doi:10.1038/onc.2011.260
68. Lee Y, Samaco RC, Gatchel JR, Thaller C, Orr HT, Zoghbi HY (2008) miR-19, miR-101 and miR-130 co-regulate ATXN1 levels to potentially modulate SCA1 pathogenesis. Nat Neurosci 11(10):1137–1139. doi:10.1038/nn.2183
69. Kovaleva V, Mora R, Park YJ, Plass C, Chiramel AI, Bartenschlager R, Dohner H, Stilgenbauer S, Pscherer A, Lichter P, Seiffert M (2012) miRNA-130a targets ATG2B and DICER1 to inhibit autophagy and trigger killing of chronic lymphocytic leukemia cells. Cancer Res 72(7):1763–1772. doi:10.1158/0008-5472.CAN-11-3671
70. Chisaka O, Kameda Y (2005) Hoxa3 regulates the proliferation and differentiation of the third pharyngeal arch mesenchyme in mice. Cell Tissue Res 320(1):77–89. doi:10.1007/s00441-004-1042-z
71. Mace KA, Hansen SL, Myers C, Young DM, Boudreau N (2005) HOXA3 induces cell migration in endothelial and epithelial cells promoting angiogenesis and wound repair. J Cell Sci 118(Pt 12):2567–2577. doi:10.1242/jcs.02399
72. Su D, Ellis S, Napier A, Lee K, Manley NR (2001) Hoxa3 and pax1 regulate epithelial cell death and proliferation during thymus and parathyroid organogenesis. Dev Biol 236(2):316–329. doi:10.1006/dbio.2001.0342
73. Thebault S, Gachon F, Lemasson I, Devaux C, Mesnard JM (2000) Molecular cloning of a novel human I-mfa domain-containing protein that differently regulates human T-cell leukemia virus type I and HIV-1 expression. J Biol Chem 275(7):4848–4857. doi:10.1074/jbc.275.7.4848
74. Chen CMA, Kraut N, Groudine M, Weintraub H (1996) I-mf, a novel myogenic repressor, interacts with members of the MyoD family. Cell 86(5):731–741. doi:10.1016/S0092-8674(00)80148-8
75. Kraut N, Snider L, Chen CMA, Tapscott SJ, Groudine M (1998) Requirement of the mouse I-mfa gene for placental development and skeletal patterning. EMBO J 17(21):6276–6288. doi:10.1093/emboj/17.21.6276
76. Kusano S, Raab-Traub N (2002) I-mfa domain proteins interact with Axin and affect its regulation of the Wnt and c-Jun N-terminal kinase signaling pathways. Mol Cell Biol 22(18):6393–6405
77. Liang H, Castro PD, Ma J, Nagarajan L (2005) Finer delineation and transcript map of the 7q31 locus deleted in myeloid neoplasms. Cancer Genet Cytogen 162(2):151–159. doi:10.1016/j.cancergencyto.2005.03.019
78. Cigognini D, Corneo G, Fermo E, Zanella A, Tripputi P (2007) HIC gene, a candidate suppressor gene within a minimal region of loss at 7q31.1 in myeloid neoplasms. Leukemia Res 31(4):477–482. doi:10.1016/j.leukres.2006.09.007
79. Gu L, Dean J, Oliveira ALA, Sheehy N, Hall WW, Gautier VW (2009) Expression profile and differential regulation of the Human I-mfa domain-Containing protein (HIC) gene in immune cells. Immunol Lett 123(2):179–184. doi:10.1016/j.imlet.2009.03.010
80. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, Bartel DP, Linsley PS, Johnson JM (2005) Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433(7027):769–773. doi:10.1038/nature03315
81. Grimson A, Farh KKH, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP (2007) MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 27(1):91–105. doi:10.1016/j.molcel.2007.06.017
82. Helwak A, Kudla G, Dudnakova T, Tollervey D (2013) Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding. Cell 153(3):654–665. doi:10.1016/j.cell.2013.03.043